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Summary
Dendritic cells (DCs) are major constituents of periph-
eral tissues, where they control immunity to foreign and
self-antigens. The process of continuous DC renewal
under homeostatic conditions is largely undefined.
Here, we demonstrate that CD14+ DC precursors, either
derived from CD34+ hematopoietic progenitor cells or
isolated from blood, were attracted by the chemokine
CXCL14, which is constitutively produced in healthy
skin and other epithelial tissues. In a tissue model we
show that human epidermal equivalents profoundly
affected CD14+ DC precursors, including their supra-
basal positioning and survival as well as their differ-
entiation into Langerhans cell-like cells with potent
antigen-presentation functions. Our model assigns
unprecedented roles to CXCL14 and epidermal tissue
as attractant and niche of differentiation, respectively,
in the renewal of Langerhans cells under steady-
state conditions.
Introduction
Antigen-presenting cells (APCs) initiate immune re-
sponses by presenting MHC bound peptides to T cells
carrying the appropriate T cell receptor. DCs are unique
among APCs since they efficiently trigger primary im-
mune responses in naive T cells that need adequate
costimulation for full engagement (Banchereau et al.,
2000; Shortman and Liu, 2002; Steinman et al., 2003).
The vast majority of DCs are present at extravascular
sites, including epithelial tissues, whereas DCs are
scarce in blood.
A hallmark of DC physiology is the functional duality
represented by two states of maturation, which are
tightly linked to tissue homeostasis and inflammation.
DCs in healthy peripheral tissues are in an “immature”
state characterized by potent microbe-sensing as well
as antigen-capture and processing capabilities. “Ma-
ture” DCs home to lymph nodes (LNs) and provide
expert antigen-presentation and T cell stimulation func-
tions. Besides a proinflammatory role, DCs are instru-
mental in maintaining peripheral tolerance to self and*Correspondence: bernhard.moser@izb.unibe.ch
3 Present address: Department of Pathology, Harvard Medical
School, The CBR Institute for Biomedical Research, Boston, Mas-
sachusetts 02115.
4 Present address: Ludwig Institute for Cancer Research (Mel-
bourne Branch), Heidelberg, Victoria, 3084, Australia.environmental antigens (Steinman et al., 2003). This
steady-state DC function involves the continuous up-
take and presentation of self-antigens under noninflam-
matory conditions for elimination of self-reactive T cells
and/or for induction of regulatory/suppressor T cells.
DCs also exist in two “migratory” states. Tissue-resi-
dent DCs express receptors for inflammatory chemo-
kines but lack CCR7, whereas mature or skin-emigrant
(semimature) DCs express CCR7 for rapid relocation to
draining LNs (Sallusto and Lanzavecchia, 2000).
DC maturation is not reversible, suggesting that the
pool of tissue-resident DCs is continuously replenished
from newly generated precursors. Although a certain
lineage plasticity cannot be excluded, myeloid DCs de-
velop from myeloid-committed precursors, which origi-
nate from CD34+ hematopoietic progenitor cells (HPCs)
in bone marrow (Shortman and Liu, 2002; Ardavin et al.,
2001). It is not clear at present if the variety of DCs in
peripheral tissues, including interstitial DCs and Lang-
erhans cells (LCs), are directly derived from a common
myeloid DC precursor or from a variety of precursor
subtypes with distinct tissue-selective homing proper-
ties. DCs are extremely rare in blood and constitute dis-
tinct types of “committed” DC precursors (Banchereau
et al., 2000; MacDonald et al., 2002). Whether they give
rise to tissue-resident DCs or represent tissue-emigrant
DCs is an open question. Cells resembling tissue-resi-
dent DCs can be generated in vitro from CD34+ HPCs
or blood monocytes (Caux et al., 1996; Sallusto and
Lanzavecchia, 1994). In addition, blood monocytes may
develop in situ into DCs (and macrophages) under in-
flammatory conditions (Randolph et al., 1999). How-
ever, the precursors that develop into tissue-resident
DCs under steady-state condition have not been iden-
tified.
Here, we hypothesized that the migration properties
of DC precursors define their final destination, where
differentiation into tissue-resident DCs may occur. Con-
sequently, studies aimed at identifying tissue chemo-
kines with selectivity for circulating DC precursors will
reveal valuable information about the site of DC devel-
opment and homeostasis. Recently, we have shown
that the chemokine CXCL14, alternatively called BRAK
(Hromas et al., 1999; Frederick et al., 2000), BMAC
(Sleeman et al., 2000), and MIP-2γ (Cao et al., 2000),
is constitutively produced in the epidermis of healthy
human skin (Kurth et al., 2001). Here we provide new
evidence that the function of CXCL14 is related to the
homeostasis of cutaneous DC. Our findings support a
model whereby CXCL14 controls the epidermal recruit-
ment of CD14+ DC precursors, which enables their in
situ differentiation into functional LC-like cells under
steady-state conditions.
Results
CXCL14 Targets in Vitro CD34+ HPC-Derived CD14+
DC Precursors and Blood Monocytes
The two major DC subsets in skin are interstitial dermal
DCs and epidermal LCs. To address the question of
Immunity
332Figure 1. CXCL14 Targets CD34-Derived CD14+ DC Precursors
(A) Transwell migration performed on cultured, unseparated CD34+
HPCs in response to 1000 nM CXCL14. CD34+ HPCs were dif-
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mXCL14 receptor by flow cytometry using biotinylated
erentiated in the presence of GM-CSF, TNF-α, SCF, and Flt-3L and
ave rise to three subsets of CD1a+, CD14+, and double-negative
DN) cells (inset). The open square depicts the migration response
f freshly isolated CD34+ HPCs. The data are representative for six
ndependent experiments.
B) Analysis of CXCL14 receptors on fresh blood CD14+ mono-
ytes, CD3+ T cells, CD19+ B cells, and CD56+ NK cells by flow
ytometry. The gray histograms show CXCL14-receptor stainings
btained with Bio-CXCL14, whereas the open histograms depict
ontrol stainings with excess of unbiotinylated CXCL14. Data are
epresentative of two experiments.
C) CXCL14-receptor expression on CD34+ HPCs and CD34+ HPC-
erived cell subsets. The upper panels show the differentiation pat-
erns and the CD14 versus CD1a gating strategy, and the lower
anels show the corresponding CXCL14-receptor expression. Note
hat CD14+ cells at day 8 of culture stained positive for CXCL14-
eceptors (R1), whereas sorted CD14+ cells after prolonged culture
day 13) ceased to express CXCL14 receptors (inset). Also, recul-
ure of sorted DN cells (R2) for another 8 days yielded CD14+ cells
R3) with only low levels of CXCL14 receptors. Data are representa-
ive of five experiments.
D) Migration of CD34+ HPC-derived DN, CD14+, and CD1a+ cells
t day 8 of culture to 1000 nM CXCL14, 10 nM CCL5, 10 nM CCL2,
00 nM CCL20, 100 nM CCL19, 100 nM SDF-1, or medium alone
control) as measured in a transwell assay on unseparated cells.
ote that each subset shows distinct levels of background migra-
ion (black line). The data represent percentage of migrated cells in
ean values ± SD (n = 6). Error bars show mean ± SEM.kin DC development in homeostasis, we examined the
esponsiveness of potential skin-homing DC precursors
o CXCL14, a chemokine with selectivity for human
lood monocytes and prominent expression in healthy
uman skin (Kurth et al., 2001). The following study is
ased on the paradigm in chemokine research that pre-
icts an intimate relationship between leukocyte migra-
ion properties and leukocyte function. Consequently,
e proposed that skin, one major site of CXCL14 pro-
uction, would influence the subset of CXCL14-respon-
ive cells among blood mononuclear cells.
First, we generated DC precursors from blood CD34+
PCs by in vitro culture, resulting in two nonoverlap-
ing subsets of CD1a+ (CD14−) and CD14+ (CD1a−) DC
recursors and a third subset of CD1a/CD14-double-
egative (DN) cells that have also lost CD34 (Figure 1A;
aux et al., 1996). These subsets appeared as early as
ay 4 of CD34+ HPC differentiation. The CD1a+ subset
ontains committed LC precursors, whereas the CD14+
ells resemble blood monocytes in their unrestricted
otential to differentiate into either macrophages, inter-
titial DCs, or LCs (Strunk et al., 1996; Jaksits et al.,
999). CXCL14 is highly selective for CD14+ cells as
videnced in a chemotaxis assay (Figure 1A). Migration
esponses peaked early, between days 6 and 10 of cul-
ure, with a net migration of 19.2% ± 2.3% input cells
mean ± SD; n = 6) and chemotactic indices (CIs) of
10, and then returned to base level by day 15. In con-
rast, CD1a+ cells and DN cells were poorly attracted by
XCL14 during the entire CD34+ HPCs differentiation
rocess. This is underscored by the low CIs of 1.3 and
.6 for CD1a+ and DN cells, respectively, reflecting mi-
or differences between CXCL14-mediated and back-
round migration.
Next, we studied the expression of the unknown
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333CXCL14 as probe. This modification did not affect func-
tion, as assessed by induction of chemotaxis and Ca2+
mobilization in monocytes (data not shown). In control
experiments, biotinylated CXCL14 uniformly stained
blood monocytes but not blood T cells, B cells, or NK
cells, as expected from functional studies (Figure 1B;
Kurth et al., 2001). CD34+ HPCs did not express
CXCL14 receptors, whereas CD14+ DC precursors at
day 8 were uniformly positive (Figure 1C). Reculturing
of sorted day 8 CD14+ cells for another 5 days did not
support further proliferation but instead resulted in
CD14+ cells that lost CXCL14 receptors (inset in Figure
1C). Also, prolonged culture of sorted DN cells for an-
other 8 days led to further proliferation and the genera-
tion of “late” CD14+ cells with borderline levels of
CXCL14 receptors (Figure 1C). These findings are in full
agreement with the transient responsiveness of CD34+
HPC-derived CD14+ cells to CXCL14 (Figure 1A) and
suggest that this chemokine targets CD14+ cells that
have newly developed from CD34+ HPCs.
At day 8 of culture, all three CD34+ HPC-derived sub-
sets responded well to a selection of additional chemo-
kines with known function in DCs and revealed distinct,
in part mutually exclusive migration profiles (Figure 1D).
DN cells responded well to CXCL12 (CI = 14.9), a chem-
okine with strong activity for CD34+ HPCs and B cells
(Moser et al., 2004), but failed to respond to other
chemokines. CD1a+ cells showed increased background
migration and responded to CCL20 (CI = 4.3), as pre-
viously reported for LC precursors (Greaves et al.,
1997), and to a lesser extent to CCL5. In clear contrast,
CD14+ cells displayed highest responses to CXCL14
and to CCL2, which is the prototype monocyte chem-
oattractant. Finally, CD14+ cells but not DN and CD1a+
cells expressed monocyte-typical cell-surface markers
(CD11b, CD11c, CD13, CD33, CD36, and CD115), indi-
cating that our CD34+ HPC culture protocol also gave
rise to monocytes (data not shown). Collectively, the
“true” CXCL14-responsive cells carry many features of
“early” monocytes, i.e., CD14+ cells that appear early
during in vitro differentiation of CD34+ HPCs.
Next, we examined CXCL14-induced migration of
CD14+ cells from human peripheral blood (see Figure
S1 in the Supplemental Data available with this article
online). Among the different subsets of monocytes
characterized by CD14 and CD16 expression, the one
expressing highest levels of CD14 (CD14high) showed
best CXCL14 responsiveness. DCs, either isolated from
blood or generated in vitro from monocytes, did not
respond. The CD14high blood monocytes resemble in
vitro generated CD34+ HPC-derived CD14+ DC precur-
sors in terms of migration and phenotypic characteris-
tics and are referred to hereafter as CD14+ DC precur-
sors to underscore their differentiation potential (see
below).
Functional CXCL14 Is Present at Strategic Locations
in Normal Human Skin
Tissue recruitment and localization of blood leukocytes
requires transendothelial migration followed by chemo-
taxis, which are two distinct processes enabling the
colocalization of mobilized leukocytes with chemokine-
producing tissue cells (Moser et al., 2004; Campbell etal., 2003). Therefore, chemokines present on blood
microvascular endothelial cells may contribute to leu-
kocyte extravasation, whereas chemokine-producing
tissue cells may define the destination of extravasated
leukocytes. Initial studies have revealed that CXCL14
transcripts are abundant in epithelial tissues, notably
in skin where epidermal keratinocytes and additional
dermal cells were shown to be the main producers
(Hromas et al., 1999; Frederick et al., 2000; Sleeman et
al., 2000; Cao et al., 2000; Kurth et al., 2001). We now
demonstrate that CXCL14 protein is associated with
dermal blood vessels and epidermal keratinocytes of
normal human skin (Figure 2A). Antibodies to CD31
stain both blood and lymphatic vessels in frozen sec-
tions, whereas antibodies to podoplanin stain preferen-
tially lymphatic vessels. Therefore, serial section analy-
sis reveals prominent CXCL14 positivity in blood
vessels in the superficial dermal plexus, although re-
duced CXCL14 positivity was also occasionally ob-
served in lymphatic vessels. CXCL14 is most abundant
in the epidermis, where it is associated with basal kera-
tinocytes as well as more differentiated keratinocytes in
suprabasal location. Epidermal expression of CXCL14
appears much more prominent than any other chemo-
kine with reported constitutive expression at this site
(Schaerli et al., 2004; Ebert et al., 2005), including
CCL1, which targets skin-selective immune surveil-
lance T cells, or CXCL12 and CCL20 with broader tar-
get cell selectivity. Obviously, epidermis needs to be
considered as a major destination of CXCL14-respon-
sive cells. In support of the CXCL14 protein data,
freshly isolated keratinocytes and dermal adherent
cells, including fibroblasts and endothelial cells, ex-
pressed CXCL14 mRNA, as evidenced by Northern blot
analysis (Figure 2B). Remarkably, treatment of these
primary cells with the proinflammatory cytokines IL-1β
and TNF-α dramatically reduced the level of CXCL14
mRNA, which is in striking contrast to inflammatory
chemokines, as exemplified here by the tremendous in-
duction of CCL20 mRNA (Moser et al., 2004; Schaerli
and Moser, 2005). Primary keratinocytes ceased to pro-
duce CXCL14 mRNA during prolonged monolayer cul-
tures (>4 passages); also, CXCL14 mRNA was not de-
tected in immortal keratinocyte and fibroblast lines.
Unfractionated tissue from small intestine served as
positive control for both CXCL14 and CCL20. Thus, un-
der physiological conditions, CXCL14 may be involved
in homeostatic as opposed to inflammatory immune
processes.
Chemokines are rapidly truncated and functionally
modified by numerous proteases that represent an ad-
ditional level of control in leukocyte traffic within tis-
sues (Moser et al., 2004). CXCL14 is unique among all
chemokines in its very short N terminus consisting of
two residues preceding the first Cys residue (NH2-
SKCKC) (Hromas et al., 1999; Frederick et al., 2000; Cao
et al., 2000). Therefore, it was important to confirm that
the keratinocyte-derived natural form of CXCL14 was
active and identical in structure to the synthetic form
used throughout our migration studies with CD14+ DC
precursors. Natural CXCL14 was purified from superna-
tants of primary keratinocyte cultures (<3 passages)
and then subjected to mass spectroscopic and amino-
terminal sequence analyses (Figure 2C). The final frac-
Immunity
334Figure 2. Functional CXCL14 Is Present in Healthy Human Skin
(A) Localization of CXCL14 protein in normal skin. Immunohistochemistry was performed on frozen tissue sections from healthy abdominal
skin. CXCL14 protein (red staining) is detected in vascular/perivascular areas within the dermis and in the epidermis (left). Asterisk marks cut
hair sheath and the inset depicts staining with a control Ab. Analysis of serial skin sections (middle and right) demonstrates overlapping
expression of CXCL14 and CD31 (blood and lymphatic vessels; open arrowheads), but not podoplanin (lymphatic vessels; filled arrowheads)
within the superficial dermal plexus.
(B) Examination of CXCL14 and CCL20 mRNA in freshly isolated and cultured human skin cells. Northern blot analysis were performed with
total RNA from keratinocytes (K) or adherent dermal cells (D), either freshly isolated or activated for 18 hr by 10 ng/ml IL-1β/TNF-α, from
keratinocyte and fibroblast (F) lines in passage 3 or related immortalized lines (HaCat for K, MDX12 for F); RNA from normal small intestinal
tissue served as positive control. Bottom panel shows ethidium bromide-stained RNA as loading control.
(C) Primary keratinocytes produce CXCL14. The inset shows the elution profile of the reversed-phase C4 column; the indicated pooled
fractions were then further purified over a CN-propyl column. CXCL14 protein was identified in the fraction eluting at 32.7 min.
(D) Migration of CD14high monocytes to natural and synthetic CXCL14, and to a series of synthetic CXCL14 variants with amino-terminal
extensions. Responses were evaluated in a modified Boyden chamber chemotaxis assay and were expressed as numbers of migrated cells
present in five random high-power fields (5HPF); background migration was <15 cells/5HPF. Error bars show mean ± SEM.tion contained a protein with MW = 9414 and the amino-
terminal sequence NH2-SKCKCSRKGP, indicating that
keratinocyte-derived CXCL14 is identical to the syn-
thetic form. More importantly, natural CXCL14 attracted
monocytes with equal or even slightly increased po-
tency than synthetic CXCL14 (Figure 2D). In contrast,
synthetic CXCL14 forms with amino-terminal exten-
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sions were inactive, demonstrating that slight amino
cid sequence variations at the amino terminus had a
rofound effect on CXCL14 activity. Finally, in cells re-
overed from healthy skin, CXCL14-responsive cells
ere identified as CD14+CD1a− mononuclear cells,
hereas, due to elevated background migration, re-
ponsiveness of the more numerous CD1a+CD14− cells
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335to CXCL14 could not be determined (see Figures S2
and S3). Together, CXCL14 protein is produced at stra-
tegic locations for extravasation and epidermal local-
ization of CXCL14-responsive cells. Accordingly, we
propose that this chemokine controls the recruitment
of CD14+ DC precursors, which may lead to their in
situ differentiation.
Localization and Survival of CD14+ DC Precursors
in Human Epidermal Equivalents
The hypothesis that epidermal tissue has an influence
on CD14+ DC precursors was tested in an artificial epi-
dermis model. Epidermal equivalents (EEs) were gener-
ated from epidermal stem cells derived from outer root
sheaths (ORS) of healthy human hair follicles (Limat and
Hunziker, 2002). These EEs lack hematopoietic cells but
express typical skin differentiation markers and show
histological features of normal human epidermis, in-
cluding a basal layer of cuboidal keratinocytes, fol-
lowed by multiple (4–8) layers of progressively flattened
keratinocytes, a stratum granulosum (3–5 layers), and
a stratum corneum, which provides barrier function in
skin (Figure 3A). EEs stained positive for CXCL14, fur-
ther underscoring tissue integrity (Figure 3B). First we
examined the effect of artificial epidermis on CD14+ DC
precursor positioning and survival in “sandwich cultures”
made from fully developed EEs and CFSE-labeled
CD14+ DC precursors. After 7 days of culture, all CFSE+
cells have entered the suprabasal layers in EEs (Figure
3C). The mechanism underlying intraepidermal posi-
tioning of CD14+ DC precursors is not clear at present.
Furthermore, the epidermal environment provided sur-
vival signals, since counting of fluorescent cells within
EEs revealed that ~1/3 of input CFSE+ cells had sur-
vived (Figure 3D). Also, a similar fraction of cells was
recovered after culturing of CD14+ DC precursor cells
on top of primary keratinocyte monolayers. This is in
striking contrast to CD14+ DC precursors that rapidly
died during culture in the absence of keratinocytes or
survival factors. Flow cytometry revealed that CFSE+
cells recovered from EEs did not proliferate (data not
shown).
Next we examined if suprabasal positioning and sur-
vival was coupled with CD14+ DC precursor differentia-
tion. The inset of Figure 3C documents the dendritic
morphology in most CFSE+ cells present within the
EEs. Also, numerous suprabasal hematopoietic (CD45+)
cells were detected in vertical sections of CD14+ DC
precursor cell-reconstituted EEs (Figure 3E). Some of
these cells expressed the DC markers CD1a and Lang-
erin (see below) and showed DC-like morphology (Fig-
ure 3F). We found that CD14+ DC precursor differentia-
tion was much more improved in EEs generated from
ORS cultures than from interfollicular keratinocytes.
Similarly critical were the coculture conditions, includ-
ing the composition of the growth factor supplement
and the time point when CD14+ DC precursors were
mixed with developing epidermis. Under these condi-
tions, immune-reconstituted EEs contained 3.2 ± 0.9
CD45+ cells/mm (4 independent experiments), which is
similar to the number of LCs in the epidermis of normal
human skin (Proksch et al., 1996). Importantly, develop-
ment of DC characteristics was not detected in cocul-tures using submersed monolayers of primary keratino-
cytes, suggesting that continuous keratinocyte differ-
entiation, a prerequisite for the formation of proper epi-
dermal architecture, is required for DC development.
This situation resembles the discrepant CXCL14 ex-
pression in keratinocyte cultures and EEs (Figures 2B
and 3B), although we do not propose that CXCL14 is
a DC differentiation factor. The importance of cellular
niches was further illustrated by the finding that dermal
fibroblasts did not support LC differentiation but rather
promoted differentiation into (CD14+, CD206+) macro-
phages and (CD1a+, DC-SIGN+, Factor XIIIa+) interstitial
DCs (see Table S1; Chomarat et al., 2000). In summary,
the epidermal environment contributes to three distinct
steps that may affect in situ development of DCs,
namely the suprabasal positioning of CD14+ DC precur-
sors as well as their long-term survival and differenti-
ation.
Epidermal Contact Turns CD14+ DC Precursors
into Functional LC-like DCs
To study the degree of CD14+ DC precursor differentia-
tion, hematopoietic cells were analyzed by flow cyto-
metry after proteolytic digestion of immune-reconstitu-
ted EEs. After 10 days of epidermal coculture, a distinct
population of hematopoietic cells (CD45+) expressing
high levels of MHC class-II molecules (HLA-DR) was
recovered showing cell-size properties (forward- and
side-scatter profiles) similar to those seen in in vitro
monocyte-derived DCs but clearly distinct from input
cells (Figure 4A). The large majority of CD45+HLA-
DRhigh cells has lost the monocyte marker CD14 but
acquired the myeloid DC markers CD1a and CD1c (Fig-
ure 4B). A substantial fraction of cells expressed sur-
face Langerin, a C-type lectin associated with Birbeck
granules (Valladeau et al., 2000), high-affinity IgE recep-
tors (FcIg-RIα), CD40, and DEC-205/CD205, indicating
the development of DCs with LC-like characteristics
(Valladeau et al., 2000; Novak et al., 2003; Inaba et al.,
1995). Other LC markers (e.g., E-Cadherin) could not be
analyzed due to sensitivity to the proteolytic treatment
of EEs. By contrast, the few surviving cells recovered
after culturing of CD14+ DC precursors for 10 days in
the absence of epidermis but in the presence of the
same media supplements retained monocytic charac-
teristics (data not shown).
Next we examined the effect of maturation stimuli on
CD14+-derived progenitor cells within EEs. For this, en-
tire immune-reconstituted EEs at 10 days of culture
were transferred to culture dishes containing medium
supplemented with or without bacterial endotoxin (LPS)
and TNF-α, followed by incubation for another 2.5 days.
HLA-DR and the costimulatory molecules CD80 and
CD86 were already expressed on immature LC-like
cells but were further upregulated during subsequent
treatment with maturation stimuli, as evidenced by flow
cytometry (compare MFI values in Figure 4C). Blood
CD14+ DC precursor cells, in contrast, lacked CD80
and expressed intermediate levels of CD86 and HLA-
DR (not shown). Interestingly, the DC maturation mark-
ers CD83 and CCR7 were not detected on “mature” LC-
like cells, in agreement with epidermal production of
TGF-β (Figure S4) and other potential inhibitors (Strobl
Immunity
336Figure 3. Localization and Survival of CD14+
DC Precursors in EEs
(A) EEs generated from outer root sheath
cells of hair follicles show well-developed
epidermal architecture. Sections were paraf-
fin embedded and stained with hematoxylin-
eosin (HE).
(B) EEs are highly positive for CXCL14 pro-
tein, as determined by immunohistochemistry
in frozen tissue sections; negative control
staining was performed with an isotype-
matched control Ab.
(C) CD14+ DC precursors move into supra-
basal location during sandwich culture with
fully developed EEs. CD14+ DC precursors
were labeled with CFSE, which allowed
tracking of cells by fluorescence micro-
scopy. Enlargement of the top view (inset) re-
veals CFSE+ cells with dendritic morphology.
(D) EEs and keratinocytes support survival of
CD14+ DC precursors. Fully developed EEs
were placed onto culture inserts seeded with
CFSE-labeled CD14+ DC precursors (black
bar) or, alternatively, CFSE-labeled CD14+
DC precursors were cultured on submersed
monolayers of primary human keratinocytes
(gray bar) and after 7 days CFSE+ cells were
counted. As control (open bar), CD14+ DC
precursors were cultured for 7 days in the
absence of EEs or keratinocytes. Surviving
cells are expressed as live (trypan blue-
negative) cells in percent of number of input
cells; data are representative of three in-
dependent experiments. Error bars show
mean ± SEM.
(E) Distribution of CD45+ cells after coculture
of CD14+ DC precursors with developing
EEs. Frozen sections of EEs were stained
with an Ab to CD45.
(F) Immune-reconstituted EEs as in (E) were
stained with an Ab to CD1a (green) and ana-
lyzed by fluorescence microscopy; nuclei
were revealed by DAPI staining (blue).and Knapp, 1999). Sorted (CD45+HLA-DR+) cells from
LPS/TNF-α-treated EEs were then tested for their abil-
ity to induce cell proliferation in a primary mixed-leuko-
cyte reaction, using highly pure naive CD4+ T cells as
responder cells. As negative and positive control APCs,
freshly isolated CD14+ DC precursors and in vitro gen-
erated, mature monocyte-derived DCs from the same
donor were used. Of note, EE-derived cells were potent
stimulators of naive CD4+ T cells and prominent prolif-
eration responses were already observed at an APC:
responder cell ratio of 1:1000 (Figure 4D). EE-derived
cells were less potent than control DCs, which may be
explained by the harsh treatment employed for extract-
ing these APCs out of EEs. Freshly isolated CD14+ DC
precursors failed to induce substantial T cell prolifera-
tion responses.
The effect of EEs on DC morphology and marker dis-
tribution was examined by microscopy. Emigrant cells
of immune-reconstituted EEs revealed a “veiled” mor-
phology, which is typical for skin emigrant cells (Figure
5A; Schuler et al., 1985; Larsen et al., 1990; Romani et
al., 1989, Lenz et al., 1993). Time-lapse video record-
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mngs demonstrate the dynamic changes in these mem-
rane lamellae (Movie S1), resembling interdigitating
Cs (Miller et al., 2004). Veiled cells were more numer-
us among emigrant cells from LPS/TNF-α-treated EEs
han from medium control EEs, in agreement with their
nhanced state of maturation (see below).
Immunocytochemical analysis of combined emigrant
nd EE-extracted cells confirmed the contrasting state
f maturation in cells derived from LPS/TNF-α-treated
Es versus control EEs (Figure 5B). Treatment of imma-
ure DCs with inflammatory stimuli results in a burst of
HC class II gene expression, which is followed by the
elocation of new and preformed MHC class II mole-
ules to the cell surface (Cella et al., 1997; Pierre et al.,
997; Chow et al., 2002). In agreement, CD14+-derived
ells from LPS/TNF-α-treated EEs showed strong cell-
urface HLA-DR staining, whereas in cells from control
Es, intracellular HLA-DR staining predominated (Fig-
re 5B, and below). EE-derived cells had long hair-like
embrane processes, highlighted by the prominent
LA-DR staining in LPS/TNF-α-exposed cells. Further-
ore, 50% of CD14+-derived cells from LPS/TNF-α-
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337Figure 4. EEs Promote Differentiation of
CD14+ DC Precursors into LC-like Cells
(A) Marker expression and cell size of freshly
purified CD14+ DC precursors that were rou-
tinely used for immune reconstitution of EEs
(top) and gating strategy to identify the prog-
eny of CD14+ DC precursors in total cell sus-
pensions of trypsinized immune-reconstitu-
ted EEs. Flow cytometry was performed on
live (propidium-iodide-negative) cells. Note
the increased FSC/SSC properties in cul-
tured CD45+HLA-DR+ cells.
(B) The progeny of CD14+ DC precursors ex-
press markers for DCs and LCs. After 10
days of coculture, CD45+HLA-DR+ cells were
analyzed by flow cytometry for the markers
as indicated. Numbers within individual plots
indicate the percentage of marker-positive
cells; data representative of three experi-
ments are shown.
(C) Immune-reconstituted EEs were cultured
for another 2.5 days in the presence or ab-
sence of LPS and TNF-α, and recovered
CD45+HLA-DR+ cells were analyzed by flow
cytometry for expression of HLA-DR (cir-
cles), CD80 (squares), and CD86 (triangles).
Filled and empty symbols refer to EEs cul-
tured in the presence or absence of LPS and
TNF-α. Data are representative of three inde-
pendent experiments.
(D) Mature LC-like cells had potent antigen-
presentation and costimulation function.
Live CD45+HLA-DR+ cells (filled circles) re-
covered from LPS/TNF-α-treated immune-reconstituted EEs, mature monocyte-derived DCs (filled triangles), and freshly isolated CD14+ DC
precursors (open squares) were analyzed in mixed-leukocyte reactions with naive heterologeous CD4+ T cells as responder cells. The three
types of APCs were derived from the same donor. Proliferation was measured by [3H]-thymidine incorporation, and the data are representative
of two independent experiments. Error bars show mean ± SEM.treated EEs uniformly expressed the maturation marker
DC-lysosome-associated membrane glycoprotein (DC-
LAMP/CD208) (Saint-Vis et al., 1998), whereas the large
majority of cells from control EEs lacked this marker
(Figure 5B, Table 1). Next, we examined the degree of
LC differentiation by staining for Langerin (Valladeau et
al., 2000). In agreement with the flow cytometry data
(Figure 4B), Langerin+ cells were readily detected in
cells from control EEs; however, this staining was weak
and mostly intracellular (Figure 5B). LPS/TNF-α treat-
ment resulted in marked upregulation of Langerin,
which has also been observed with in vitro generated
LCs (Valladeau et al., 1999, 2000; Geissmann et al.,
2002). The frequency of Langerin+ cells among CD14+-
derived cells from LPS/TNF-α or medium-treated EEs
compared well with HLA-DR+ emigrant cells from epi-
dermal sheets of normal skin (Table 1).
Confocal fluorescence microscopy confirmed the in-
tracellular-to-cell surface redistribution of HLA-DR dur-
ing in situ exposure of LC-like cells to LPS and TNF-α
(Figure 6A; Cella et al., 1997; Pierre et al., 1997; Chow
et al., 2002). The distribution of HLA-DR in LC-like cells
from control EEs largely colocalized with the late endo-
somal and lysosomal marker LAMP-1/CD107a; how-
ever, during the treatment with LPS/TNF-α, the LAMP-1
staining clustered intracellularly, whereas HLA-DR
staining gained in intensity and moved to cell surface.
This situation is further documented in video recordings
of sequential confocal planes (Movies S2–S5). Finally,Langerin staining in LC-like cells from control EEs was
weak and predominantly intracellular, whereas treat-
ment with LPS plus TNF-α resulted in increased Lang-
erin staining, part of which colocalized with cell-surface
HLA-DR. In summary, our epidermal coculture model
allowed efficient in situ differentiation of CD14+ DC pre-
cursors into LC-like cells with potent APC function.
Discussion
The molecular mechanisms underlying DC relocation to
inflammatory sites and tissue-draining LNs are becom-
ing increasingly clear (Sallusto and Lanzavecchia, 2000).
The opposite is true for the traffic control of DC precur-
sors under steady-state conditions, notably in the set-
ting of DC development in epithelial tissues. CCL2 was
proposed to control DC (and macrophage) develop-
ment at inflammatory sites by means of attracting
CCR2+ blood monocytes (Lu et al., 1998; Merad et al.,
2002). However, this inflammatory chemokine is un-
likely to play a role in DC development under steady-
state conditions. CCL20, the single ligand for CCR6,
attracts skin-emigrant CD14+ cells as well as LC-like
cells derived from CD34+ HPCs or monocytes (Larre-
gina et al., 2001; Dieu et al., 1998; Yang et al., 1999;
Sato et al., 2000). In CCR6-deficient mice, DCs are ab-
sent in the subepithelial dome of Peyer’s patches within
intestinal mucosa, whereas DCs in normal skin are not
affected (Cook et al., 2000; Varona et al., 2001). Also,
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338Figure 5. Morphologic and Phenotypic Char-
acteristics of Immature and In Situ Matured
LC-like Cells
(A) Phase-contrast microscopy of live emi-
grant cells collected after 2.5 days treatment
of immune-reconstituted EEs with LPS and
TNF-α. Note numerous veiled-type mem-
brane protrusions that are continuously re-
tracted and newly formed (Movie S1). Scale
bars equal 10 m.
(B) Immunocytochemical analysis of cyto-
spin preparations with cells recovered from
immune-reconstituted EEs after treatment
for 2.5 days with (LPS/TNF) or without (Me-
dium) LPS and TNF-α. Cells analyzed for in-
dicated markers included a combination of
emigrant and EE-extracted cells. Scale bars
equal 10 m; images are representative of
three independent experiments.CXCL14 contributes to the development of LC-like cells
Table 1. Immunocytochemical Analysis of Epidermis-Derived LC-like Cells
Immunolabeled Cells
Tissue Treatment HLA-DR DC-LAMP Langerin
EEa Medium 10.5% (8.2%–12.8%)b 0.1% (0.0%–0.1%) 4.2% (1.5%–7.0%)
LPS/TNF 10.3% (7.1%–13.6%) 4.9% (4.7%–5.2%) 4.1% (3.1%–5.0%)
Epidermisc Medium 17.0% (13.5%–20.5%) 12.7% (10.7%–14.7%) 7.3% (4.8%–11.4%)
a Immune-reconstituted EEs were treated with (LPS/TNF) or without (Medium) LPS and TNF-α for 2.5 days, and cytospins of Ficoll Hypaque-
enriched cell preparations containing emigrated cells together with EE-extracted cells were analyzed by immunocytochemistry for marker
expression.
b Number of marker-positive cells in percent of total cells that included leukocytes and an excess of keratinocytes. The fraction of HLA-DR+
cells serves as an internal reference value for evaluating the degree of DC-LAMP and Langerin expression. Total cells counted ranged from
1020 to 6240, and numbers in parentheses indicate the range of marker-positive cells between cytospin preparations of two independent
experiments.
c For comparison, epidermal sheets from normal human skin were cultured in medium for 2.5 days, and emigrant cells were analyzed by
immunocytochemistry. Note that this procedure resulted in the release of numerous tissue cells.
perficial dermal plexus as well as within the epidermis,CCL20 is low in normal human skin but is highly upreg-
ulated in inflammation, which is in line with the pres-
ence of CCR6 on effector/memory T cells and a role for
this chemokine system in inflammatory as opposed to
homeostatic processes (Moser et al., 2004).
Here, we provide evidence for our hypothesis that
u
d
u
a
s
Cnder steady-state conditions. First, CXCL14 is readily
etected in healthy human skin and is not further
pregulated in skin diseases, such as psoriasis and
topic dermatitis (data not shown), indicating a homeo-
tatic function for this ill-defined chemokine. Second,
XCL14 protein is present on blood vessels in the su-
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339Figure 6. Mobilization and Intracellular Distri-
bution of DC Markers during In Situ Matura-
tion of LC-like Cells
Confocal immunofluorescence microscopy
of single cells within cytospin preparations
as described in Figure 5B. LPS/TNF and Me-
dium refer to the treatment of immune-recon-
stituted EEs with or without LPS and TNF-α.
Scale bars equal 10 m, DIC stands for digi-
tal interference contrast images, and Overlay
refers to the combined fluorescence signals
in single midplane sections. Asterisk de-
notes two unlabeled keratinocytes. Data
from one out of three independent analyses
are shown.two distinct sites defining leukocyte extravasation and
tissue localization, respectively (Moser et al., 2004).
Third, CXCL14 is uniquely selective for CD14+ DC pre-
cursors, either generated in vitro from CD34+ HPCs or
isolated as CD14high monocytes from blood and
CD14+CD1a− cells from dermal skin tissue, respec-
tively. This chemokine does not attract other types of
myeloid cells (including blood DC subsets and mono-
cyte-derived DCs/LCs) or other cell lineages (including
T, B, and NK cells). This restricted target cell selectivity
is in clear contrast to other chemokines, which gen-
erally attract multiple types of leukocytes. Of note, the
minor subset of CD14lowCD16+ blood monocytes showed
only limited chemotaxis toward CXCL14. It was demon-
strated that this type of monocytes or corresponding
phagocytic cells preferentially undergoes differentiation
into DCs during reverse transmigration, which occurs
when tissue-resident phagocytes enter the lymphatic
system (Randolph et al., 1998, 2002).
Abundant expression of CXCL14 in the epidermis led
us to propose that CXCL14 mediates the epidermal re-
cruitment of CXCL14-responsive CD14+ DC precursors,
thereby promoting their in situ differentiation into func-
tional DCs. In a coculture model employing artificial
EEs, we show that intraepidermal localization had pro-
found effects on CD14+ DC precursors. CD14+ DC pre-
cursors migrated into the suprabasal layer of keratino-
cytes, which is the primary location of epidermal LCs.
EEs also provided survival signals that prevented
extensive cell death of CD14+ DC precursors. Most im-
portantly, a large fraction of CD14+ DC precursors ac-quired a LC phenotype, characterized by expression of
DC and LC markers (Banchereau et al., 2000; Shortman
and Liu, 2002; Steinman et al., 2003). We wish to point
out that CD14+ DC precursor development in our model
using EEs did not depend on exogenous DC survival
and differentiation factors. In fact, we have no knowl-
edge of an alternative system yielding a similar degree
of DC differentiation in the absence of supplements
containing combinations of GM-CSF, Flt-3L, TNF-α,
TGF-β, etc. In addition, these LC-like cells matured in
situ in response to inflammatory stimuli, as assessed
by HLA-DR and DC-LAMP expression as well as acquisi-
tion of veiled cell morphology (Schuler et al., 1985;
Larsen et al., 1990; Romani et al., 1989; Valladeau et
al., 1999, 2000; Geissmann et al., 2002). Finally, in situ
matured LC-like cells were functional, as evidenced by
potent induction of proliferation responses in naive T
cells.
In summary, our model assigns a critical function to
CXCL14 and epidermal tissue in the homeostasis of hu-
man skin DCs. CXCL14 may control the epidermal re-
cruitment of circulating DC precursors, whereas intact
epidermal tissue provides structural and functional
niches for DC development, i.e., CXCL14 and epidermal
tissue work in sequential but independent fashion. Hu-
man CXCL14 mRNA is also expressed in other epithe-
lial tissues, including intestinal tract, airways, and kid-
ney (Kurth et al., 2001; Hromas et al., 1999; Frederick
et al., 2000), suggesting that our model of DC homeo-
stasis may be extended to skin-unrelated tissues. The
present coculture system using immune-reconstituted
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340EEs will provide an invaluable tool for future studies on
LC differentiation.
Experimental Procedures
The data on antibodies and cytokines, CXCL14 receptor stainings,
and purification of natural CXCL14 are described in Supplemental
Experimental Procedures.
Culture Media
RPMI medium consisted of RPMI 1640 plus 2 mM L-glutamine, 1%
nonessential amino acids, 1% sodium pyruvate, 50 g/ml penicil-
lin/streptomycin, 5 × 10−5 M β2-ME (all Invitrogen, Basel, Switzer-
land), and 10% FCS (Biological Ind., Israel). DMEM medium con-
sisted of DMEM (4.5 mg/ml glucose; Invitrogen) plus 10% FCS, 2
mM L-glutamine, 1% nonessential amino acids, 50 g/ml penicillin/
streptomycin (Invitrogen), 5 × 10−5 M β2-ME. F medium consisted
of 3 parts DMEM and 1 part Ham’s F12 (PAA Labs, Austria) plus 20
mM HEPES, 0.135 mM adenine (Sigma, St. Louis, MO), 5 g/ml
insulin (Invitrogen), 10 ng/ml EGF, 0.4 g/ml hydrocortisone (Sigma),
2 nM triiodthyronine (Sigma), 100 U/ml Penicillin, 100 g/ml strepto-
mycin, 10% FCS. K medium was F medium plus 10 ng/ml cholera
toxin (Sigma), and K+ medium was K medium plus 50 g/ml
L-Ascorbic acid (Sigma). RPMI/F12 medium consisted of 3 parts
RPMI medium and 1 part Ham’s F12 plus 20 ng/ml EGF, 5 mM
HEPES and 3.5 mg/ml D-glucose.
Blood Cell Isolation and Culture
PBMCs were isolated from fresh blood of healthy individuals by
Ficoll centrifugation. HPCs were isolated from PBMCs by positive
selection of CD34+ cells using the MACS system (Miltenyi Biotech).
CD34+ cells were seeded at 35,000 cells/cm2/ml in DMEM medium
plus 100 ng/ml GM-CSF, 2.5 ng/ml TNF-α, 10 U/ml SCF, 50 ng/ml
Flt-3L. After 4 days, 0.5 ml/cm2 of fresh DMEM medium plus GM-
CSF/TNF-α was added. Total monocytes for transwell assays were
isolated from PBMCs by negative depletion of CD3+, CD8+, CD19+,
CD20+, CD34+, and CD56+ cells. CD14high monocytes for cocul-
tures were isolated from CD1c-depleted PBMCs by positive selec-
tion of CD14high cells. MDCs were isolated from lin-depleted
PBMCs by positive selection of CD1c+ cells. PDCs were isolated
from lin- and CD11c-depleted PBMCs and identified as CD4high
CD123high cells in transwell assays. Monocyte-derived DCs and
LCs are described elsewhere (Sallusto and Lanzavecchia, 1994;
Geissmann et al., 1998). DCs/LCs were matured in the presence of
100 ng/ml LPS (Salmonella abortus equi) and used within 8–48 hr
for transwell assays. For functional studies, DCs were matured with
500 ng/ml LPS and 10 ng/ml of each IL-1β and TNF-α for 2 days.
Naive CD4 T cells were isolated from PBMCs by negative depletion
of CD1c+, CD8+, CD14+, CD16+, CD19+, CD20+, CD25+, CD33+,
CD34+, CD45RO+, CD56+, and γδ-TCR+ cells using FITC or PE-
labeled secondary MACS Ab (Miltenyi Biotech).
Skin Cell Isolation and Culture
All skin cells were isolated from normal abdominal split skin (thick-
ness 0.5 mm). Dermal cells were isolated after digestion of split
skin with 1.25 U/ml Dispase II for 15 min (Roche Diagnostics
GmbH, Mannheim, Germany) to remove epidermis, and then re-
maining dermal tissue was digested with 0.2 U/ml Collagenase D
(Roche) for 45 min at 37°C in RPMI 1640 in a slowly tilting dish.
Adherent dermal cells were collected after plastic adherence for 2
hr in complete RPMI or after stimulation with IL-1β/TNF-α (each
10 ng/ml) for 18 hr. Primary fibroblast lines were established from
adherent cells in F medium. Immortalized dermal fibroblast line
MDX12 was from MODEX Therapeutiques (Lausanne, Switzerland).
Keratinocytes were derived from epidermal sheets peeled off from
split skin after digestion with Dispase II for 20 min at 37°C. Then,
epidermal sheets were trypsinized for 15 min at 37°C to obtain an
epidermal cell fraction containing highly enriched keratinocytes.
Primary keratinocyte lines were established in serum-free medium
(10744; Invitrogen) or in F medium by seeding fresh keratinocytes
in feeder dishes containing 4500/cm2 irradiated (70 Gy) dermal fi-
broblasts (<5 passages). Skin or epidermal emigrant cells were ob-
tained by placing split skin or epidermal sheets on RPMI medium
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Lor 6–48 hr followed by a Ficoll purification of cells present within
he culture medium.
pidermal Equivalents and Cocultures
pidermal equivalents (EEs) were generated from ORS cells as de-
cribed (Limat and Hunziker, 2002). In brief, 200,000 epidermal
tem cells, derived from a 7–14 day preculture of ORS of hair folli-
les, were seeded in 500 l of K medium into a cell culture insert
Corning Costar) carrying 200,000 irradiated (70 Gy) primary dermal
ibroblasts on the undersurface, i.e., stem cells were separated
rom fibroblasts by the membrane insert. Dermal fibroblasts were
erived from primary cultures (p < 5). “Sandwich culture” refers to
ntact EEs that were placed onto the membrane of new inserts,
ontaining fibroblasts on the lower side and DC precursors on the
pper side. DC precursors were seeded into the insert and allowed
o attach on the membrane for 1 hr before medium was completely
emoved and cells were covered with the EEs. For generation of
mmune-reconstituted EEs, inserts were cultured in K+ medium un-
il stem cells reached confluence, then washed several times with
PMI and covered with 200,000 freshly isolated autologous
D14high monocytes for 2 hr in RPMI/F12 medium. Then, all me-
ium in the upper well was carefully removed and 1 ml RPMI/F12
edium in the lower well was replaced every day until analysis
after 1–2 weeks). For in situ maturation, immune-reconstituted EEs
ere transferred using forceps to new tissue culture dishes con-
aining culture medium with or without 500 ng/ml LPS and 10 ng/
l TNF-α, and the EE were cultured for another 2.5 days before
rocessing. Leukocytes were recovered by cutting the EEs into
mall pieces and processing by digestion in 1× trypsin/EDTA for
0 min at 37°C, mechanical dispersion by vigorous pipetting, and
iltering trough a 70 m pore mesh. Flow cytometry was done using
ulk cells and gating on live (propidium-iodide−) CD45+HLA-DR+
ells, whereas cells were further purified by Ficoll centrifugation for
reparation of cytospins. To track leukocytes within EEs, mono-
ytes were labeled with 0.5–5 M CFSE (Molecular Probes, Leiden,
he Netherlands) in PBS containing 5% FCS for 4 min at room tem-
erature.
unctional Assays
ranswell chemotaxis assays were performed with mixed cell pop-
lations for 1.5 hr using 5 m pore polycarbonate filter inserts
Corning Costar Corp., Cambridge, MA). 48-well chemotaxis cham-
ers of 5 m pore size were used for the comparative analysis of
atural and synthetic CXCL14 preparations (Schaerli et al., 2004).
n the T cell proliferation assay, titrated numbers of 2× sorted
D45+CD33+ APCs (either progeny cells of cocultured CD14+ DC
recursors or in vitro generated, mature monocyte-derived DCs)
ere incubated with 50,000 heterologous naive CD4+ T cells in 250
l RPMI medium per 96 U bottom well. [3H] thymidine incorporation
as measured after 5 days. Northern blot analyses with RNA ex-
racted by the RNAzole B method (Tel-Test Inc., Friendswood, TX)
ere performed as described elsewhere (Kurth et al., 2001).
mmunohistochemistry
ormal human skin samples from abdominal and mammary reduc-
ion surgery were frozen at −80°C in Tissue Tek O.C.T. Compound
Sakura, Zoeterwoude, Netherlands). Freshly prepared 5 m tissue
ections were blocked with human IgG at 3 mg/ml (Redimune, ZLB
ioplasma AG, Bern), 10% donkey (Jackson ImmunoReasearch) or
abbit (DakoCytomation) serum, 0.01% Tween 20, and 0.01% so-
ium azide in Tris-buffered saline. Acetone-fixed sections were in-
ubated overnight at 4°C with primary mouse Ab to CXCL14, CD31,
D1a, CD45, rabbit polyclonal Ab to podoplanin, murine isotype
ontrol Ab IgG2a, IgG1, or rabbit IgG. Primary Ab were detected by
iotinylated donkey anti-mouse or donkey anti-rabbit Ab. Subse-
uent detection was performed by the ABC method (Kurth et al.,
001). EEs were either formaldehyde fixed and paraffin embedded
or classical haematoxylin-eosin stain or frozen in O.C.T. com-
ound. Alternatively, formaldehyde- or acetone-fixed cytospins of
ells extracted from immune-reconstituted EEs (TNF/LPS- or me-
ium-treated) and human epidermal cells (spontaneously emi-
rated) were labeled with primary HLA-DR, DC-LAMP, Langerin,
AMP-1, and isotype control Ab in the presence of 1% saponin for
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341cell permeabilization. For confocal immunofluorescence micro-
scopy, cytospins were double labeled with Cychrome-conjugated
HLA-DR and either PE-conjugated Langerin or LAMP-1 Ab under
permeabilizing conditions. Cytospins were mounted in Mowiol and
examined using a Zeiss LSM510Meta confocal laser scanning
microscope.
Supplemental Data
Supplemental data include three figures, one table, five movies,
and Supplemental Experimental Procedures and can be found with
this article online at http://www.immunity.com/cgi/content/full/23/
3/331/DC1/.
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